Systemic sclerosis portends increased risk of conduction and rhythm abnormalities at diagnosis and during disease course: A US population-based cohort
Yasser Radwan(Mayo Clinic), Ashima Makol(Mayo Clinic), Rekha Mankad(Mayo Clinic in Arizona), Eric L. Matteson(Mayo Clinic), Reto Kurmann(Mayo Clinic), Cynthia S. Crowson(Mayo Clinic), Kenneth J Warrington(Mayo Clinic in Arizona), Thomas G. Osborn(Mayo Clinic in Arizona), Avneek Singh Sandhu(Mayo Clinic in Arizona), Edward El‐Am(Mayo Clinic in Arizona)
Cited by 9
Related Papers
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis Care & Research|2015|1.1k